tiprankstipranks
Trending News
More News >
ALK-abello A/S Class B (AKBLF)
OTHER OTC:AKBLF

Compare ALK-abello (AKBLF) vs. Competitors

Compare
14 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
ALK-abello
$31.90
$7.09B
42.31
52.09%
0 Buy
0 Hold
0 Sell
Moderate Buy
Inovio Pharmaceuticals
$1.58
$109.17M
-9.60
-18.56%
1 Buy
1 Hold
0 Sell
Moderate Buy
Aclaris Therapeutics
$3.69
$445.00M
-4.66
135.03%
3 Buy
0 Hold
0 Sell
Strong Buy
Emergent Biosolutions
$8.19
$424.00M
12.57
42.93%
1 Buy
0 Hold
0 Sell
Moderate Buy
Novartis
$146.03
$279.08B
19.02
28.99%
2 Buy
4 Hold
0 Sell
Moderate Buy
Bristol-Myers Squibb
$57.48
$117.06B
15.61
-4.87%
8 Buy
11 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKBLF
ALK-abello
31.90
11.47
56.13%
DVAX
INO
Inovio Pharmaceuticals
1.58
-0.30
-15.96%
ACRS
Aclaris Therapeutics
3.69
1.99
117.06%
EBS
Emergent Biosolutions
8.19
2.46
42.93%
NVS
Novartis
146.03
37.07
34.03%
BMY
Bristol-Myers Squibb
57.48
-0.63
-1.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts